In sporadic AD, the apolipoprotein E (APOE) ε4 variant raises the risk of developing AD by three to fifteen times,6, 7 and a further 83 AD‐related genetic loci have been identified in a recent genome‐wide association study (GWAS).5 The gene discussed is APOE; the disease is Alzheimer disease.